Prof. Anita E. Weidmann, MRPharmS, MFRPSII, SFHEA, PhD is the Head of the Clinical Pharmacy Department at the University of Innsbruck, Austria. She is a visiting Prof. at the and the Karl-Franzens University in Graz, Austria and the Robert Gordon University, Aberdeen. She has previously held positions at the School of Pharmacy and Life Sciences in Aberdeen, Scotland; the Apoptosis Research Institute at the Children’s Hospital of Eastern Ontario, Canada and the Hospital Pharmacy Department of Addenbrookes Hospital in Cambridge, UK. She is an Associate Editor for the International Journal of Clinical Pharmacy and the European Journal of Hospital Pharmacy and on the Editorial Board Research and Social Administrative Pharmacy. She is a member of the Research Committee for the European Society of Clinical Pharmacy; a member of the Scientific Committee for the Austrian Patient Safety Platform and an advisor on several expert groups for the Austrian Ministry of Health.

Prof. Weidmann has a long list of peered reviewed publications which centre around her research focus, Medication Therapy- and Patient Safety. She is interested in patient-centred issues, evaluation-based research of existing clinical services; needs assessments for the development of clinical services to inform legislative changes and academic curricula; as well as implementation research for clinical pharmacy services. Her current research addresses the optimizing drug therapy safety of high-risk medications; developing a comprehensive medication risk tool for the avoidance of delirium in hospitalised patients or the development of clinical pharmacy services in hospital pharmacies. She has a wide international research network and as PI has most recently been awarded the paper of the year award 2022 by the International Journal of Clinical Pharmacy.